Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. - Wikidata - wikimedia - TriplyDB

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

http://www.wikidata.org/entity/Q34497097

about

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?The treatment of neuromyelitis optica.The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.Clobetasol promotes remyelination in a mouse model of neuromyelitis optica Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders.Intracerebral Injections and Ultrastructural Analysis of High-Pressure Frozen Brain Tissue.

P2860

Q28245749-4C2E6DA0-552C-470F-A249-66618329D5F1 Q30842875-4B916D12-32AF-4683-A1A7-10DE86540971 Q33911142-46246D18-E7CC-4060-81A3-6C757BF2D186 Q34399291-F049094F-5231-43AD-B370-D74BBD389448 Q35242214-9A886984-0005-4E0F-863B-4AE3475E7BBC Q35583116-C95B2BF5-3572-47B0-9E7E-252B1ED09BE8 Q36348690-72709025-B324-4EF3-A732-D87C4268A57D Q36562604-2EFC09FF-9E07-461D-89A0-9F49149A6F2E Q36836541-419061B7-967B-468F-A492-C486B80DA7C5 Q37104869-962E63F9-6480-44D3-BBC5-6630961E5BD4 Q37252524-3A0DA4BB-0D9B-4569-8050-899230BF0898 Q37466478-7777D0EA-A931-48F9-86B3-E7734E9703D2 Q37708381-25B3EEF5-4092-4EC6-A63C-0C7427709BAA Q38954323-E083D818-531E-4D9F-97E0-32D9EDDA0529 Q42844764-31413B47-E41C-43ED-A69C-060FE91CB8C0 Q46591339-83C8ED57-1EFA-4BAD-9FEF-A60E529F8349 Q48334547-8E263730-C1C8-4B46-8784-E8989A8C0C7E Q48374186-9CF8EA34-EF09-416D-98A3-B068288B985E

P2860

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

http://www.wikidata.org/entity/Q34497097

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@ast

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@en

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@nl

type

label

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@ast

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@en

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@nl

prefLabel

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@ast

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@en

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@nl

P1433

Q34497097-76E6551B-C14E-438F-BBFF-FC419A318ABC

P1476

Q34497097-487896CF-3339-45DD-8662-138557C7C4F5

P2093

Q34497097-38270557-CBDB-4C8E-9087-4DD3B995BE2F

Q34497097-3DA713A4-E5F1-4F03-810B-45D6DD452BFF

Q34497097-7148742F-B2B3-49F7-8DF0-B539D4707565

Q34497097-895DD424-5B5D-4D1E-A0F0-7B185960FEEF

Q34497097-D099D97C-BDFC-4674-B8EB-704CB9219DEC

Q34497097-D615A97E-80F1-4AE3-B42E-7D27C77E999C

Q34497097-D886B0AE-0742-429A-8CCC-81107A69CB5B

Q34497097-DE6B395C-0081-4973-8D1A-52599CF6C92B

P2860

Q34497097-0779B316-77F3-49AA-BCFA-013CD3701DC2

Q34497097-0AEB4BB9-A6CC-4E6B-98AA-8AC03D834553

Q34497097-0B17E5A6-D936-4655-8910-E860280B486C

Q34497097-18654C1B-91F2-42DD-8144-A0F72222CB51

Q34497097-1BDD8D81-5E62-4E33-9E3F-2E2078F20060

Q34497097-2070A0C7-A517-46C4-965A-B5CB6E287AA5

Q34497097-27BCFC4B-C403-4C21-A9C9-4EB6D89A6655

Q34497097-2B1C7939-F21C-4447-8A54-0D1EB3C0A7A7

Q34497097-2EE37B91-8189-41A1-8F11-A7CF0A071C55

Q34497097-2FC68B9A-74EC-4DFE-899C-DED6704B5006

P2888

Q34497097-2242450E-2AC3-4198-A38A-0B07F8B91ED7

P304

Q34497097-08BBCD9B-734A-4B8A-A592-0D30FD8CA300

P31

Q34497097-951C38AE-B31A-4DFA-A74A-6F288CEDF720

P356

Q34497097-33C69EFB-CCD5-4B13-9627-F87425413FB3

P433

Q34497097-004CDE52-0007-4627-AA88-265BAA403021

P478

Q34497097-4B277FC5-94AE-4E4E-BCC6-83E3231D020C

P50

Q34497097-0B09C6A1-8144-4D02-8AF7-2B14A8601A02

Q34497097-A6CFDD5D-12FC-44E0-B483-8A8E2AF85555

P577

Q34497097-D23B2568-03A7-4E05-8C11-6C7B1D7475F3

P698

Q34497097-63AC62B3-5E9D-4174-91F6-E73BB260C959

P921

Q34497097-63467038-CAC2-4500-877F-27FEBDD2306C

P932

Q34497097-AEFDA609-F5D6-4956-A1F6-0A8AF73C2A62

P356

S00401-013-1220-8

P1433

Acta Neuropathologica

P1476

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

@en

P2093

Anne Winkler

http://www.w3.org/2001/XMLSchema#string

Christiane Wegner

http://www.w3.org/2001/XMLSchema#string

Claudia Wrzos

http://www.w3.org/2001/XMLSchema#string

Dieter M Kayser

http://www.w3.org/2001/XMLSchema#string

Imke Metz

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Bennett

http://www.w3.org/2001/XMLSchema#string

Stefan Nessler

http://www.w3.org/2001/XMLSchema#string

Wolfgang Brück

http://www.w3.org/2001/XMLSchema#string

P2860

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate

Neuromyelitis optica and anti-aquaporin 4 antibody--an overview

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

P2888

s00401-013-1220-8

P304

523-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-013-1220-8

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Dietmar R. Thal

Christine Stadelmann

P577

2013-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24292009

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

4229038

http://www.w3.org/2001/XMLSchema#string